0001883850-22-000068.txt : 20220912 0001883850-22-000068.hdr.sgml : 20220912 20220912163144 ACCESSION NUMBER: 0001883850-22-000068 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220908 FILED AS OF DATE: 20220912 DATE AS OF CHANGE: 20220912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bassler Bonnie L CENTRAL INDEX KEY: 0001683607 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 221238915 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-09-08 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001683607 Bassler Bonnie L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2022-09-08 4 M 0 1279 391.92 A 2361 D Common Stock 2022-09-08 4 S 0 1279 705.0 D 1082 D Common Stock 2022-09-08 4 M 0 1279 391.92 A 2361 D Common Stock 2022-09-08 4 S 0 1279 686.99 D 1082 D Common Stock 2022-09-09 4 M 0 609 376.69 A 1691 D Common Stock 2022-09-09 4 S 0 609 741.0 D 1082 D Non-Qualified Stock Option (right to buy) 376.69 2022-09-09 4 M 0 609 0.0 D 2027-01-03 Common Stock 609 610 D Non-Qualified Stock Option (right to buy) 391.92 2022-09-08 4 M 0 1279 0.0 D 2026-09-09 Common Stock 1279 3839 D Non-Qualified Stock Option (right to buy) 391.92 2022-09-08 4 M 0 1279 0.0 D 2026-09-09 Common Stock 1279 2560 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 1,279 shares of Company stock on September 8, 2022 at prices ranging from $705.00 to $705.06. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 8, 2022 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. /s/** Bonnie L. Bassler 2022-09-09